INTRODUCTION 46 47
Fish oils are rich in omega-3 polyunsaturated fatty acids (n-3 PUFAs) and are the most common non-48 vitamin non-mineral supplements in the United States, taken by 10% of adults (7). They are frequently 49 consumed during pregnancy because of claimed benefits to neurodevelopment of the offspring, 50 particularly in childhood. However, the evidence for neurodevelopmental benefits from n-3 PUFAs 51 intake during pregnancy is poor (42), and a recent report showed no effects on objective assessments of 52 cognition, language, and executive function at 4 years of age (44). Furthermore, a recent systematic 53 review and meta-analysis showed no benefit of n-3 PUFAs during pregnancy on pre-eclampsia, intra-54 uterine growth retardation, post-partum depression, or childhood development (53). In contrast, a 55 number of animal studies have shown adverse effects on neurological development of the offspring 56 following a maternal diet rich in n-3 PUFAs (13, 14, 30, 51) , although in some the dose would be 57 unrealistic for a human diet (13, 14) . Nonetheless, in New Zealand for example, 15% of women 58 undergoing fertility treatment (27) and approximately 20% of pregnant women (20) were taking fish oil. 59
The global consumption of n-3 PUFA supplements continues to grow, despite the increasing number of 60 studies failing to show improvements in hard outcomes (28) . 61
62
Pregnancy is a critical time period when considering the safety of medications, and the same should 63 apply to dietary supplements. Fetal life is a highly vulnerable stage, when complex embryological 64 3 processes can be disrupted by external factors (such as chemicals) that may be harmless to the mother 65 (62). Further, perinatal factors play an important role in programming body composition and cardio-66 metabolic risk later in life (26, 32) . 67
68
The n-3 PUFAs in fish and other marine oils (e.g. krill, calamari, and algae) are easily oxidised to a 69 variety of lipid peroxides and other secondary oxidation products (54). In a recent comprehensive 70 survey of fish oil products on the New Zealand market, 83% exceeded the recommended level of lipid 71 peroxides, 33% by more than two fold (4). In addition, 25% exceeded the recommended level of 72 secondary oxidation products (aldehydes and ketones) (4). Similar results have been demonstrated in 73 studies from North America (36, 50) and Africa (48). This implies that most women taking fish oil 74 during pregnancy are routinely exposed to oxidation products. Further, antioxidant status is reduced 75 during pregnancy (24) and extremely low in the early embryo (60), so that pregnancy may be a time of 76 special vulnerability to lipid peroxides. However, there is insufficient evidence to establish a safe level 77 of oxidation in fish oils for consumption (2, 19) . 78
79
In animal models, exposure to oxidised lipids has been shown to cause harm, including growth 80 retardation, organ toxicity, and accelerated atherosclerosis (3, 22, 57) . However, the effects of 81 consuming oxidised lipids during pregnancy are unknown (2). For this reason, in a study primarily 82 designed to investigate the effects of fish oil supplementation during pregnancy on the adult offspring 83 of rats fed a high-fat diet, we have also included oxidised fish oil groups. As obesity is associated with 84 increased oxidative stress (23) and greater production of oxidised lipids (37), the effects of an oxidised 85 lipid supplement may be more marked in obese mothers. This manuscript describes the effects of the 86 oxidised fish oil on neonatal viability and maternal insulin sensitivity, while examining for a possible 87 interaction with a maternal obesogenic diet. 12-h dark cycle. Animals were assigned to one of two isocaloric diets ad libitum for ten days prior to 101
The treatment fish oil was produced from hoki (Macruronus novaezelandiae) liver (Seadragon Marine 139 Oils, Nelson, New Zealand). Half of the oil was frozen and used as the 'unoxidised fish oil' (UnFO). 140
The remainder was treated by bubbling oxygen for 30 days under a fluorescent lamp at room 141 temperature to produce the 'oxidised fish oil' (OxFO). Oxidation was assessed by measuring the 142 peroxide value (PV) and anisidine values (AV) (15). The unoxidised oil had a PV of 1.5 meq/kg and 143 AV of 0.6, which are well within recommended indices of oxidation (25, 31, 58) and lower than those 144 of any fish oil available on the New Zealand market (4). In contrast, the oxidised oil had PV of 48.8 145 meq/kg and AV of 4.5, greatly exceeding recommended levels (25, 31, 58) . The fatty acid content of 146 both oils was measured independently by gas chromatography ( Corporation, Tokyo, Japan) with all coefficients of variation (CV) less than 6%. Insulin was measured 159 by rat-specific ELISA (Crystal Chem, Illinois, USA) with CV of 11%. Total superoxide dismutase 160 (SOD) activity was measured with a commercial enzyme assay kit as per the manufacturer's 161 instructions (Sapphire Bioscience, Mulgrave, Australia) with a CV less than 6%. An EIA kit was used 162 to measure the DNA oxidation by-product 8-hydroxy-2-deoxy guanosine (8-OH-2dG) as a marker of 163 oxidative stress (59). DNA was extracted from samples using a DNA isolation kit (Promega, Sydney, 164 Australia). Each sample was then diluted, so that 50 mg of DNA were used in the 8-OH-2dG assay, 165 which was carried out as per the manufacturer's instructions (Sapphire Bioscience, Mulgrave, 166 Australia) with a CV of 3.5%. 167
168

Statistical analyses 169 170
Rat dam outcomes were compared between groups using general linear regression models. Newborn 171 survival was assessed using generalized linear mixed models, including the dam identification code as a 172 random factor. Offspring outcomes were assessed using random effects mixed models, also including 173 the dam identification code as a random factor. Dietary intake over the course of the study was assessed 174 using linear regression models with repeated measures. Note that all models assessing the effects of6 gavage also adjusted for diet (high-fat or control). The associations between SOD and 8-OH-2dG were 176 evaluated using Pearson's correlation coefficients and simple linear regressions. Statistical analyses 177 were carried out in SAS v.9.4 (SAS Institute, Cary, NC, USA) and Minitab v.16 (Pennsylvania State 178 University, State College, PA, USA). All tests were two-tailed with significance level maintained at 179 5%. Unless stated otherwise, data in the text are means. 180
181
RESULTS
183
There was no evidence of an interaction between gavage treatment and maternal diet for the two main 184 outcomes of interest (maternal insulin sensitivity and newborn survival) or most other study parameters. 185
Thus, to better characterise the effects of oxidised fish oil and to increase statistical power, the dams 186 and litters exposed to the same gavage treatment were pooled into the three groups: UnFO, OxFO, and 187
Control. 188 189
Pregnancy & newborn survival 190 191
Of the 75 rat dams that were mated, 49 became pregnant and successfully had pups, including 17 dams 192 in Control, 17 in UnFO, and 15 in OxFO. Supplementation (fresh fish oil, oxidised fish oil, or water) 193 had no effect on litter numbers, sex ratio of the offspring, or frequency of non-pregnancy. However, 194 oxidised fish oil during pregnancy had a marked adverse effect on offspring survival at day 2, leading to Amongst pups who were alive at day 2, supplementation had no effect on body weight of live pups, but 202
UnFO pups were longer than controls (+1.3 mm; p=0.041) ( Table 2 ). There were no differences in 203 relative organ weights amongst the culled offspring at day 2, or in random blood glucose, FFA, total 204 protein, AST, CK or LDH concentrations (Table 3 ). However, SOD activity was higher in the UnFO 205 group (0.20 U/ml) compared with Control (0.14 U/ml; p=0.001) and OxFO (0.15; p=0.005) pups, while 206 8-OH-2dG levels were lower in the UnFO group (48 pg/ml) compared with Control (63 pg/ml; 207 p=0.023) ( Table 3 ). In addition, SOD activity and 8-OH-2dG were inversely correlated among UnFO 208 pups (r=-0.65; p=0.001), but not among the other two groups (Figure 4) . 
Maternal outcomes 214 215
At weaning (postnatal day 21), dams in the three gavage groups were of similar size and had similar 216 organ weights (data not shown). However, dams supplemented with oxidised fish oil had higher fasting 217 blood glucose concentrations (5.56 mmol/l) than dams from Control (4.80 mmol/l; p=0.012) and UnFO 218 (4.72 mmol/l; p=0.007) groups (Table 2) . Dams from the oxidised group were also more insulin 219 resistant than controls, as indicated by differences in HOMA-IR (p=0.044; Table 2) . 220 221
Maternal high-fat diet vs control diet 222 223
There was no evidence of an interaction between maternal diet and gavage treatment for the main study 224 outcomes, pregnancy parameters, litter characteristics, or most other outcomes examined. A significant 225 interaction between diet and gavage was only observed for SOD activity and liver weight (Table 4) . 226
Unoxidised fish oil gavage led to increased SOD activity (p<0.001 vs Control; p<0.0001 vs OxFO), but 227 only amongst pups exposed to a maternal control diet (Table 4) . Unoxidised fish oil led to a reduction in 228 relative liver weight of pups only when the dam consumed a high-fat diet (p=0.022 vs Control; p=0.020 229 vs OxFO). This was not observed with the control diet (Table 4) . Among rat dams fed a control diet, 230
OxFO dams had higher fasting glucose (p=0.007) and tended to be more insulin resistant (p=0.051) 231 than those who received control gavage (Table 4 ). There appears to have been a similar effect amongst 232 dams fed a high-fat diet, but there was reduced statistical power due to lower numbers of dams in the 233
OxFO group (Table 4) . In this trial of fish oil supplementation during rat pregnancy, oxidised fish oil led to an 8-to 13-fold 238 increase in the odds of newborn mortality. Importantly, there was no increase in mortality in the groups 239 fed unoxidised fish oil compared to controls, indicating that the adverse effect on newborn survival was 240 due to the presence of lipid oxidation products. Further, dams exposed to the oxidised fish oil in 241 pregnancy were more insulin resistant at weaning, which was the end of the study and 21 days after last 242 exposure. However, the effects of the oxidised fish oil on the newborn pup survival did not differ 243 between dams consuming a high-fat or a control diet. This suggests that the known adverse effects of a 244 high-fat diet on maternal metabolism (17, 33) did not alter the toxicity of oxidised fish oil to newborn 245 pups. These data show that lipid peroxides formed in oil rich with n-3 PUFA are harmful in rat 246 pregnancy, raising the possibility that they may also have an adverse effect in human pregnancy. 247
8
The oxidised fish oil was characterised by a high concentration of lipid peroxides, which could have 249 caused oxidative stress (and the consequent toxic effects). Oxidative stress has important effects during 250 pregnancy, as it contributes to the teratogenic effects of drugs (61) and has a role in complications such 251 as spontaneous abortion, pre-eclampsia and intrauterine growth restriction (1). Oxidised lipids influence 252 placental development, lipid metabolism, and lipid transport (37), and lipid peroxide levels are 253 markedly higher in serum and placenta of pre-eclamptic pregnancies (24). Thus, in principle, the 254 increased newborn mortality in the OxFO group could have been mediated by effects on maternal and 255 placental health. Alternatively, lipid peroxides could have crossed the placenta and directly affected the 256 fetus, but there is only weak evidence to suggest that lipid peroxides can cross the placenta (52). 257
258
Our findings indicate that the redox effects of oxidised and unoxidised fish oils on the pups differed. 259 However, it was not possible to determine the mechanisms underlying the increased newborn mortality, 260 or whether oxidative stress played a role. Nonetheless, previous studies showed that fish oil 261 supplementation increases endogenous antioxidant enzymes (21) and reduces oxidative damage (16, 262 21) . Consistent with these studies, supplementation with unoxidised fish oil was associated with 263 reduced 8-OH-2-dG levels (a marker of oxidative DNA damage in the pups) and increased activity of 264 superoxide dismutase (SOD, a key antioxidant enzyme). Further, 8-OH-2-dG and SOD activity were 265 negatively correlated among the UnFO pups. In contrast, neither these beneficial effects nor the 266 correlation between 8-OH-2-dG and SOD were observed in the OxFO pups. It should be noted that due 267 to limited amount of blood samples that can be extracted from newborn pups, markers of lipid and 268 protein oxidative damage could not be measured. 269
270 Surprisingly, and at odds with the high newborn mortality in the OxFO group, no differences were 271 identified between groups for a range of markers of cellular toxicity (e.g. FFA, CK, and LDH) or in 272 body weight or relative organ mass. However, the earliest samples collected were from offspring alive 273 on postnatal day 2 (at the time of a planned cull to standardize litter size), when a large number of pups 274 had already died. Consequently, there was a 'healthy survivor' bias, i.e. the most severely affected pups 275 had died and could not be assessed, so that we sampled those least affected by the toxicity of the 276 oxidised fish oil. 277 278 Interestingly, oxidised fish oil supplementation dams led to greater insulin resistance in dams 3 weeks 279 beyond the last dose. Furthermore, as the mothers were culled at this stage, we do not know whether 280 this effect would have been sustained even longer (i.e. a long-term reprogramming of metabolism). 281
Conversely, no insulin-sensitising effect of unoxidised fish oil was apparent 3 weeks after the end of 282 supplementation. Short-term improvements in insulin sensitivity with n-3 PUFAs have been 283 demonstrated in rodents (34, 46, 56) , but it is likely that this effect was lost in our unoxidised fish oil 284 group over time. Nonetheless, we report for the first time that oxidised fish oil increases insulin9 resistance, the opposite effect reported for unoxidised fish oil (34, 46, 56) . The cause of this increased 286 insulin resistance is unknown, but it could be due to induction of systemic inflammation, as oxidative 287 stress activates the proinflammatory NF-κB pathway (41), which is central to the inflammation 288 associated with obesity and insulin resistance (8, 35, 55) . 289
290
Our findings cannot be extrapolated directly to humans. However, it is clear that the dose of lipid 291 peroxides used in this study was high. For a woman to consume an equivalent dose of lipid peroxides 292 [i.e. 890 meq/m 2 /day based on surface area (49)] from a retail supplement (4), she would have to take at 293 least 40 ml of oxidised fish oil per day. Thus, it is very unlikely that women taking fish oil during 294 pregnancy would be exposed to such a high dose of lipid peroxides. Nevertheless, no safe level of 295 peroxide exposure has been established in humans, and pregnancy is a time of special vulnerability, 296
where endogenous antioxidant status is reduced (24). 297
298
Many possible causes for the variability of outcomes in trials of n-3 PUFAs in pregnancy have been 299 raised (11). However, the potential for oxidation to change the biological activity of trial oils has not 300 been recognised (2). As oxidised fish oil induced maternal insulin resistance in this study, it is possible 301 that trials and meta-analyses assessing the effects of fish oil on a range of outcomes (including 302 gestational diabetes, birth weight, and offspring metabolism) may have been confounded by oxidation 303 (2). 304
305
Our study had a number of strengths. First, we used an oxidised fish oil that was derived from the fresh 306 fish oil, and thus identical except for the presence of oxidation products. Second, we utilized small 307 frozen aliquots of trial oils with delivery by gavage, which ensured the correct dose was given, and that 308 inadvertent oxidation of the unoxidised oil did not occur. Third, the control dams also underwent daily 309 gavage to prevent confounding by the stress of the procedure itself (9). However, this study also has 310 limitations. It was not designed to identify the mechanism of harm, and assessment of pups on day 2 311 (after 25% of pups had died in the OxFO group) introduced a 'healthy survivor' bias, and could not 312 discriminate between stillborn pups and those that died after delivery. Further, the dose used and the 313 severity of oxidation was relatively high, and the possible effects of lower doses in human pregnancy 314 cannot be extrapolated. 315
316
Perspectives and significance 317 318
This is the first study to show negative effects of oxidised fish oil in pregnancy, specifically, increased 319 maternal insulin resistance and increased newborn mortality in rats. It represents an important proof of 320 concept that supplementation with oxidised fish oil in pregnancy may be harmful. This is relevant as 321 fish oil supplements are often oxidised at the time of purchase (4, 36, 48, 50) , and are commonly taken 322 during pregnancy. Therefore, there is a pressing need for studies examining dose-response relationships 323 between oxidised fish oil consumption and pregnancy outcomes. Given our findings, the lack of 324 compelling evidence that fish oil supplementation is beneficial in human pregnancy (53), and previous 325 studies showing adverse effects (6, 29, 40, 44) , caution is advised when considering taking fish oil 326 supplements in pregnancy. However, it should be pointed out that our findings are unlikely to apply to 327 fresh oily fish. Clinical trials of n-3 PUFAs should ensure that adopted supplements are independently 328 verified to be unoxidised, and their oxidative state should be reported. Lastly, future studies should 329 focus on three particular aspects: 1) whether there is a dose-response relationship between lipid 330 peroxide intake and both maternal and newborn outcomes, and whether doses more comparable to 331 human supplementation are also harmful; 2) whether the addition of antioxidants can mitigate any 332 adverse outcomes; and 3) the identification of the exact mechanisms leading to newborn mortality 333 (including a wider range of markers of oxidative stress and assessments in fetal life). Virgin female rats were randomised to control or high-fat diet. T2: Females were mated and further 505 randomised to one of the three gavage treatments, i.e. unoxidised fish oil (UnFO), oxidised fish oil 506 (OxFO), or water (Control). T3: on postnatal day 2 pups were counted, sexed and weighed; excess pups 507 were culled and samples taken. T4: on postnatal day 21 pups were separated, while dams were culled 508 and had samples taken. Values in boxes represent the number of dams, except at T3 where the total 509 number of pups at day 2 is also provided in parentheses. in the packed blood cells of rat pups exposed to maternal gavage with water (A), unoxidised fish oil 519 (B), or oxidised fish oil (C). Blood samples were collected from rat pups that were alive at day 2 and 520 culled on this day. 521 522 Table 4 . Study outcomes on rat dams (post-weaning day 22) and on culled rat offspring (postnatal day 2) according to maternal diet (Control or High-fat) and 552 type of gavage treatment during pregnancy: water (Control), unoxidised fish oil (UnFO), or oxidised fish oil (OxFO). Data are means ± standard errors (except 553 for data on glucose homeostasis that are geometric means and 95% confidence intervals), with offspring data adjusted for sex. Note that aside from glucose, all 554 offspring biochemical markers were performed in a reduced group, where pups were randomly selected from each litter. Also note that two pups in each OxFO 555 group had blood taken for biochemistry but did not have organs weighed. 556
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